 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Home Phillips, Harris, Horowitz, et al hit the target squarely. Their concern is the overriding significance of an invisiblized but nonetheless serious infection caused by an extraordinarily complex neurotropic spirochete. Its pandemic is approaching severity that was experienced throughout the world in the Spanish Flu of 1918. The causative spirochete is, of course, less immediately fatal than was the virus of that epidemic, but it is deadly, nonetheless, to the human brain. (1) The fact that the causative spirochete, B. burgdorferi, is being studied as an agent of biowarfare in the USA(2) adds impetus to a need for quick education of most of the world’s academic physicians as to what has been sensed at the clinical level for a long time: we are dealing here with a formidable "smart stealth" type of bacteria that is hard to eradicate--one that does extreme damage to psyche and soma if not treated aggressively over the long term when missed in the first days following inoculation by the vector. (Announced recently: "UTSA Opens New Bioterrorism Lab--A new research lab for bioterrorism opened Monday at the University of Texas at San Antonio. [San Antonio AP]. The $10.6 million M. B. Tobin Laboratory Building will provide a 22,000-square-foot facility to study such diseases as anthrax, tularemia, cholera, Lyme disease, desert valley fever and other parasitic and fungal diseases. The Centers for Disease Control and Prevention identified these diseases as potential bioterrorism agents.")(3) An excerpt from a patent application related to biowarfare research reads: "We plan to use Borrelia burgdorferi, the arthropod-borne etiologic agent of Lyme disease and Yersinia pestis, the etiologic agent of plague, as our principle test agents to work through the systems. We will begin with B. burgdorferi since although it has a complicated life-cycle involving both arthropod and animal intermediates, it is easy to grow and we have extensive experience in working with it in different complex environments including ticks, rodents and human samples." (4) Medicine worldwide has not been successful in dealing with persistent Lyme by maintaining its concept of it as a geographically localized nuisance disease caused by a simple spirochete previously described as "Easy to diagnose (Bull’s Eye rash, swollen major joint, Bell’s palsy, etc.) and easy to treat (One day to 3 weeks of an antibiotic)." Organized Medicine has mostly ignored or deserted the field of neuro-Lyme’s currently immense proportions, internationally. The diagnosis and treatment of human Lyme as led by the "diagnose-and-treat-by-the-old-Guidelines" types of powerful but passé medical thinking, the clinging to outdated medical dogma about tick-borne diseases, is no longer tolerable.
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Print Article